- Home
- NAUT vs CBAN Comparison
NAUT vs CBAN Comparison
Compare NAUT & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAUT | CBAN |
|---|---|---|
| Founded | 2016 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.0M | 282.0M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | NAUT | CBAN |
|---|---|---|
| Price | $1.92 | $17.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 227.3K | 98.9K |
| Earning Date | 10-28-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.60% |
| EPS Growth | N/A | ★ 26.78 |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | ★ $122,550,000.00 |
| Revenue This Year | N/A | $20.97 |
| Revenue Next Year | N/A | $25.65 |
| P/E Ratio | ★ N/A | $11.14 |
| Revenue Growth | N/A | ★ 12.48 |
| 52 Week Low | $0.62 | $13.99 |
| 52 Week High | $2.54 | $18.80 |
Technical Indicators
Market Signals| Indicator | NAUT | CBAN |
|---|---|---|
| Relative Strength Index (RSI) | 49.65 | 49.28 |
| Support Level | $1.89 | $17.96 |
| Resistance Level | $2.05 | $18.80 |
| Average True Range (ATR) | 0.13 | 0.31 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 40.30 | 14.29 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.